Sichuan Hebang Biotechnology Corporation Limited

Shanghai Stock Exchange 603077.SS

Sichuan Hebang Biotechnology Corporation Limited Price to Sales Ratio (P/S) on January 14, 2025: 1.89

Sichuan Hebang Biotechnology Corporation Limited Price to Sales Ratio (P/S) is 1.89 on January 14, 2025, a -23.97% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Sichuan Hebang Biotechnology Corporation Limited 52-week high Price to Sales Ratio (P/S) is 2.72 on February 07, 2024, which is 44.10% above the current Price to Sales Ratio (P/S).
Sichuan Hebang Biotechnology Corporation Limited 52-week low Price to Sales Ratio (P/S) is 1.70 on September 18, 2024, which is -10.02% below the current Price to Sales Ratio (P/S).
Sichuan Hebang Biotechnology Corporation Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 2.11.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Shanghai Stock Exchange: 603077.SS

Sichuan Hebang Biotechnology Corporation Limited

CEO	Mr. Xiaoping Zeng
IPO Date	July 31, 2012
Location	China
Headquarters	Building C6
Employees	7,169
Sector	Materials
Industries Chemicals & Advanced Materials Biotechnology Petrochemicals Pharmaceuticals

Description

Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company also provides original glass and smart glass, special glass, low-e coated glass, and photovoltaic packaging materials and products, as well as photovoltaic glass and module products. In addition, it engages in the supply of oil and gas. The company was formerly known as SichuanHebang Biotechnology Co.,Ltd. and changed its name to Sichuan Hebang Biotechnology Corporation Limited in April 2021. Sichuan Hebang Biotechnology Corporation Limited was founded in 2002 and is based in Chengdu, China.

Key trends

Past 5 years